-The Hindu Business Line India can learn from Brazil’s Bolsa Familia and China’s Gansu Programme to make refinements to its MGNREGA scheme. The development experiences of Brazil, China and India provide a valuable opportunity to understand the relationship between growth and distribution over periods of high rates of growth. The growth story playing out in all the three emerging economies have resulted in large regional as well as spatial inequalities, between rural and...
More »SEARCH RESULT
Total Matching Records found : 3430
Odisha's tribals to take on Hindalco -Hrusikesh Mohanty & Dillip Satapathy
-The Business Standard About 15 kms from the idyllic hilly town of Semiliguda in South Odisha’s Koraput district, the stage is set for an encore of the Niyamgiri-type agitation, as the tribals gather at the foothills of Mali Parbat to protest against bauxite mining by Hindalco Industries Ltd in the area. Sharing the concerns of the Dongria Kondh tribe at Niyamgiri, whose protests had put a halt to Vedanta’s bauxite mining plan...
More »India aims to cap fertility rate at 2.1 by 2017-Mahendra Kumar Singh
-The Times of India India aims to meet the much-awaited goal of reaching the total fertility rate(TFR) — the average number of children born to a woman —to 2.1% by the end of 12th five year plan (2012-17). The Planning Commission is likely to set the TFR target of 2.1 in its 12th Plan document, which is likely to be cleared by National Development Council (NDC) in October. "India is on...
More »Infant mortality rate alarms health officials in Thane-Nitin Yeshwantrao
-The Times of India THANE: With 252 infants reported to have died soon after birth in the last four months (April -July 2012) in Thane district, the health department's initiatives to save premature babies or those affected by illness has come under severe scrutiny. The cause of major worry is the high rate of new born mortality here as, out of the 252 infants who died 152 were less than a year...
More »Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »
